July 28, 2014 1:13 PM ET

Pharmaceuticals

Company Overview of Corgentech Inc.

Company Overview

As of December 15, 2005, Corgentech Inc. was acquired by AlgoRx Pharmaceuticals Inc., in a reverse merger transaction. Corgentech, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States. It focuses on treatment of cardiovascular disease, inflammatory diseases, and cancer. The company is developing transcription factor decoys and aptamers that treat disease through the regulation of gene expression. Its product candidates include E2F Decoy, a combination drug and delivery device, for the prevention of coronary artery bypass graft failure; NF-kB Decoy, which is used for the treatment of Eczema; and HIF Decoy for the ...

650 Gateway Boulevard

South San Francisco, CA 94080

United States

Founded in 1999

132 Employees

Phone:

650-624-9600

Key Executives for Corgentech Inc.

Corgentech Inc. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
The Rugby Group, Inc. United States
Pelias Technologies, Inc. United States
Palmetto Pharmaceuticals, Inc. United States
Juventas Therapeutics, Inc. United States
The Synergy Company of Utah, LLC United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Corgentech Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.